{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:00:07Z","timestamp":1781168407466,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.thromres.2026.109731","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:09:06Z","timestamp":1780474146000},"page":"109731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["APTTO: a clot waveform analysis\u2013based algorithm for diagnostic triage of prolonged activated partial thromboplastin time"],"prefix":"10.1016","volume":"262","author":[{"given":"Diego","family":"Velasco-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Revilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mah\u00edllo-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vega-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ortega-Carriedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Vidal","family":"Laso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Mart\u00ednez-Alfonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Salvatierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Llamas-Sillero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2026.109731_bb0005","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1046\/j.1538-7836.2003.00459.x","article-title":"The partial thromboplastin time: defining an era in coagulation","volume":"1","author":"White","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109731_bb0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/rth2.12252","article-title":"Prolonged APTT of unknown etiology: a systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit","volume":"3","author":"Barbosa","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109731_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0042-1756706","article-title":"Clot waveform analysis for monitoring hemostasis","volume":"49","author":"Nogami","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109731_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-0716-3175-1_9","article-title":"Performance and interpretation of clot waveform analysis","volume":"2663","author":"Ruberto","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2026.109731_bb0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.12287","article-title":"Towards standardization of clot waveform analysis and recommendations for its clinical applications","volume":"11","author":"Shima","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109731_bb0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3343\/alm.2023.43.6.531","article-title":"Clot waveform analysis for hemostatic abnormalities","volume":"43","author":"Wada","year":"2023","journal-title":"Ann. Lab. Med."},{"issue":"3","key":"10.1016\/j.thromres.2026.109731_bb0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1613023","article-title":"The utility of activated partial thromboplastin time (APTT) clot waveform analysis in the investigation of hemophilia A patients with very low factor VIII activity","volume":"87","author":"Shima","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2026.109731_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1538-7836.2006.01730.x","article-title":"Measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay","volume":"4","author":"Matsumoto","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109731_bb0045","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1111\/hae.13266","article-title":"Clot waveform analysis using CS-2000i\u2122 distinguishes between very low and absent factor VIII activity in severe hemophilia A","volume":"23","author":"Matsumoto","year":"2017","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2026.109731_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ijlh.13347","article-title":"Overall hemostasis potential and APTT-clot waveform analysis as diagnostic tools for identifying hemophilia A patients with unexpected bleeding phenotype","volume":"43","author":"Milos","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109731_bb0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MBC.0000000000000436","article-title":"Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP analyzer for detecting factor deficiencies","volume":"27","author":"Tokunaga","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109731_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-019-0201-0","article-title":"Usefulness of the APTT waveform for diagnosis of DIC and prediction of outcome or bleeding risk","volume":"17","author":"Suzuki","year":"2019","journal-title":"Thromb. J."},{"issue":"6","key":"10.1016\/j.thromres.2026.109731_bb0065","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/01.CCM.0000217471.12799.1C","article-title":"Activated partial thromboplastin time waveform analysis: a new tool to detect infection?","volume":"34","author":"Chopin","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2026.109731_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.258","article-title":"Diagnostic analysis of lupus anticoagulant using clot waveform analysis in prolonged APTT: a retrospective study","volume":"4","author":"Kanouchi","year":"2021","journal-title":"Health Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","article-title":"A study of atypical APTT derivative curves on the ACL TOP coagulation analyser","volume":"33","author":"Solano","year":"2011","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001721-200201000-00002","article-title":"Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies","volume":"13","author":"Su","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"6","key":"10.1016\/j.thromres.2026.109731_bb0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1751-553X.2007.00979.x","article-title":"Prognostic implications of a biphasic waveform for APTT analysis in a district general hospital","volume":"30","author":"Mair","year":"2008","journal-title":"Int. J. Lab. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109731_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.33160\/yam.2022.08.013","article-title":"Differences in the composition of APTT reagents affect clot waveform analysis","volume":"65","author":"Kato","year":"2022","journal-title":"Yonago Acta Med."},{"issue":"3","key":"10.1016\/j.thromres.2026.109731_bb0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bjs.9736","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"102","author":"Collins","year":"2015","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.thromres.2026.109731_bb0100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4065\/82.7.864","article-title":"How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults","volume":"82","author":"Kamal","year":"2007","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ajcp\/107.1.105","article-title":"Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing","volume":"107","author":"Adcock","year":"1997","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.thromres.2026.109731_bb0115","series-title":"NCCLS Document H21-A4","article-title":"Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays: approved guideline\u2014fourth edition","author":"Arkin","year":"2003"},{"issue":"11","key":"10.1016\/j.thromres.2026.109731_bb0120","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the ISTH SSC for lupus anticoagulant detection and interpretation: update of the guidelines","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2026.109731_bb0125","first-page":"1080","article-title":"Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors","volume":"104","author":"Ruinemans-Koerts","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-0038-1645678","article-title":"Monitoring heparin therapy: relationship between the APTT and heparin assays based on ex-vivo heparin samples","volume":"63","author":"Van den Besselaar","year":"1990","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109731_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.mbc.0000169217.15926.d0","article-title":"Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents","volume":"16","author":"Francis","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2026.109731_bb0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/j.1875-9114.1991.tb04294.x","article-title":"Influence of heparin on the prothrombin time","volume":"11","author":"Schultz","year":"1991","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116835","article-title":"Monitoring low-molecular-weight heparins at therapeutic levels: dose-responses of, and correlations and differences between APTT, anti-factor Xa and thrombin generation assays","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2141.2003.04196.x","article-title":"Low-molecular-weight heparins: are they all the same?","volume":"121","author":"White","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109731_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0049-3848(02)00340-7","article-title":"In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on coagulation tests","volume":"107","author":"Linkins","year":"2002","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1309\/AJCPY6G6ZITVKPVH","article-title":"The effect of dabigatran on select specialty coagulation assays","volume":"139","author":"Adcock","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.thromres.2026.109731_bb0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1373\/clinchem.2012.189704","article-title":"The laboratory and the new oral anticoagulants","volume":"59","author":"Tripodi","year":"2013","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.thromres.2026.109731_bb0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pathol.2018.11.008","article-title":"Laboratory testing for lupus anticoagulant in patients on DOAC treatment","volume":"51","author":"Favaloro","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.thromres.2026.109731_bb0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2019.11.001","article-title":"Potential usefulness of activated charcoal (DOAC-Remove\u00ae) for dRVVT testing in patients receiving direct oral anticoagulants","volume":"184","author":"Jourdi","year":"2019","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109731_bb0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.16091","article-title":"A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove","volume":"187","author":"Cox-Morton","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rth2.12264","article-title":"Effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: can activated carbon eliminate false-positive results?","volume":"4","author":"De Kesel","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2026.109731_bb0195","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood.V100.7.2522","article-title":"Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a calcium-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation","volume":"100","author":"Toh","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0200","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1038\/s41598-020-71063-1","article-title":"Assessment of APTT-based clot waveform analysis for detecting hemostatic changes in infections","volume":"10","author":"Tan","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2026.109731_bb0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:35:26Z","timestamp":1781166926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S0049384826001507"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109731","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APTTO: a clot waveform analysis\u2013based algorithm for diagnostic triage of prolonged activated partial thromboplastin time","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109731"}}